My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Revlimid 25 mg hard capsules



Bristol-Myers Squibb Pharma EEIGEU/1/07/391/004

Main Information

Trade NameRevlimid 25 mg hard capsules
Active SubstancesLenalidomide
Dosage FormCapsule, hard
Licence HolderBristol-Myers Squibb Pharma EEIG
Licence NumberEU/1/07/391/004

Group Information

ATC CodeL04AX Other immunosuppressants
L04AX04 lenalidomide

Status

License statusAuthorised
Licence Issued14/06/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable ListLenalidomide 25mg Capsules
Interchangeable List CodeIC0125-022-001
Interchangeable List DocumentPDF of Interchangeable List
« Back
Follow medicine

Print